Skip to Primary Menu Skip to Utility Menu Skip to Main Content Skip to Footer
Cure Alzheimer's Fund Logo Cure Alzheimer's Fund Logo

Research Professor and Chair of the Program “Homeostasis of Tissue and Organs,” Center for Molecular Biology Severo Ochoa, CSIC-UAM, Madrid, Spain

Paola Bovolenta is investigating the contribution of a small protein molecule, secreted frizzled related protein 1 (SFRP1), in the progression of Alzheimer’s disease. Based on encouraging initial data, Dr. Bovolenta’s lab now is validating an antibody against this protein as a possible treatment to slow Alzheimer’s disease progression.

“Cure Alzheimer’s Fund is giving us the opportunity to explore whether SFRP1 is a valuable target for Alzheimer’s disease treatment. The financial support is certainly very important, but the real difference has been the idea that ‘someone’ was ‘trusting and believing’ in what we were proposing. This has been way more important than the money, at least to me, especially because we are newcomers in the field of Alzheimer’s disease.”

To learn about the Bovolenta Lab, click here.